Page last updated: 2024-08-21

indazoles and pp242

indazoles has been researched along with pp242 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huang, X; Liu, H; Qian, W; Wei, J; Xiao, F; Yang, C; You, L	1

Other Studies

1 other study(ies) available for indazoles and pp242

Article	Year
PDK1 inhibitor GSK2334470 exerts antitumor activity in multiple myeloma and forms a novel multitargeted combination with dual mTORC1/C2 inhibitor PP242. Oncotarget, 2017, Jun-13, Volume: 8, Issue:24 Topics: 3-Phosphoinositide-Dependent Protein Kinases; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Female; Humans; Indazoles; Indoles; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Mice; Mice, SCID; Multiple Myeloma; Purines; Pyrimidines; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2017

Article

Year

PDK1 inhibitor GSK2334470 exerts antitumor activity in multiple myeloma and forms a novel multitargeted combination with dual mTORC1/C2 inhibitor PP242.

Oncotarget, 2017, Jun-13, Volume: 8, Issue:24

Topics: 3-Phosphoinositide-Dependent Protein Kinases; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Female; Humans; Indazoles; Indoles; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Mice; Mice, SCID; Multiple Myeloma; Purines; Pyrimidines; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2017